QIA:FRA
Qiagen NV
40,90 €
arrow_upward
+0,85%(+0,35) 1D
13 հոկ, 11:46:18 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for QIA...
Open
40,30 €
High
40,90 €
Low
40,30 €
Mkt. cap
8,48 մլրդ
Avg. vol.
539,00
Volume
0,00
Dividend
0,75%
Quarterly dividend
0,08 €
Ex-dividend date
07 հլս, 2026 թ.
P/E ratio
23,57
52-wk high
48,80 €
52-wk low
27,86 €
EPS
1,74 €
Shares outstanding
226,24 մլն
No. of employees
6 հզր
Open
40,30 €
High
40,90 €
Low
40,30 €
Mkt. cap
8,48 մլրդ
Avg. vol.
539,00
Volume
0,00
Dividend
0,75%
Quarterly dividend
0,08 €
Ex-dividend date
07 հլս, 2026 թ.
P/E ratio
23,57
52-wk high
48,80 €
52-wk low
27,86 €
EPS
1,74 €
Shares outstanding
226,24 մլն
No. of employees
6 հզր
News stories
From web sources and news partners
ad-hoc-news.de
·
30 րոպե առաջ
BofA raises target for Qiagen stock to USD 50.00
Simply Wall Street
·
16 ժամ առաջ
Did AI Research Tools Just Shift Qiagen's (QGEN) Investment Narrative?
Profile
QIAGEN N.V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research. The company operates in more than 35 offices in over 25 countries. QIAGEN N.V., the global corporate headquarter of the QIAGEN group, is located in Venlo, The Netherlands. The main operative headquarters are located in Hilden, Germany. European, American, Chinese, and Asian-Pacific regional headquarters are located respectively in Hilden, Germany; Germantown, Maryland, United States; Shanghai, China; and Singapore. QIAGEN's shares are listed at the NYSE and at the Frankfurt Stock Exchange in the Prime Standard. Thierry Bernard is the company's Chief Executive Officer. Wikipedia
About Qiagen NV
CEOThierry Bernard
Employees5,5 հզր
Founded29 նոյ, 1984 թ.
HeadquartersՎենլո, Լիմբուրխ, Նիդեռլանդներ
Sector-
Websiteqiagen.com